The short version: I'm giving Peptide South Africa 7 out of 10, the best grade of the other SA shops in this series. Their newer posts on the law, recalls and doping are genuinely excellent: sourced, dated and honest about what the evidence can't prove. Their lab reports are labelled more honestly than anyone else's. But the same blog still has older posts giving injection doses and cycles, one says research peptides are “legal to sell and possess”, and the site sells a monthly fat-loss programme with dosing instructions. That's why the claims check is red.
What I looked at: peptide-south-africa.com, all 36 blog posts (24 read in full), 41 linked PubMed references, the lab-testing page, 10 product pages, the fat-loss programme, quiz, reviews page, FAQ and policies. All on 15 October 2026.
The score, broken down
| What I marked | Score | Why |
|---|---|---|
| Is it clear? | 2 / 2 | Short-answer boxes, tables, “what this can and can't tell you” panels, and dated source checks. Plain, well organised writing throughout. |
| Is it useful? | 1 / 2 | The regulation and lab-report posts are useful to any South African, buyer or not. But about a third of the blog is personal dosing advice, and posts lead into “protocol” bundles. |
| Are the facts right? | 1 / 2 | Most checks hold, including every doping-list line and the recall details. Some don't: the “legal to sell and possess” claim, a pancreatitis rule, a mislabelled trial. |
| Does it show the evidence? | 1 / 2 | 35 of 36 posts link sources, almost all primary. But 16 of 41 PubMed links open an unrelated paper, all in older posts. |
| Is it honest about downsides? | 2 / 2 | The bluntest of any SA seller: SAHPRA's warning in half its posts, side-effect and drop-out rates, and lines like “animal healing research is not clinical proof”. |
| Total | 7 / 10 | The best writing I've graded, sharing a blog with the worst habit in the category. |
The supplier checks
| Check | Result | Why |
|---|---|---|
| Lab reports | Amber | Named lab, task numbers, dates and verify links, honestly labelled as supplier samples with no batch. Most product pages openly say “COA PENDING”. But there's no report for any of their own batches, while other pages still promise every batch is tested. |
| Claims & dosing | Red | Clean product pages, but blog posts with injection doses and cycles, “our Cape Town clinics”, and a paid programme delivering supply “with clear dosing and timing instructions”. |
| Basics | Amber | A company name, registration number and named director, policies and an editorial policy. But two different addresses, no VAT number, and the same “verified” reviews on several products. |
What they got right
The best evidence writing I've graded in SA. Their peptide cheat sheet, the GLP-1 recall explainer and the post on peptides in sport link primary sources, date when they checked them, and say what each source can and can't show. Every reference I checked in the cheat sheet led to the right source, and every line of their doping table matches the 2026 prohibited list.
They say the uncomfortable thing. “BPC-157: animal healing research is not clinical proof.” Their recall post explains that a “research use only” label does not establish registration, safety or that a product works, and they quote SAHPRA's warning against products like the ones they sell. No other shop I've graded does that.
Honest lab-report labels. Their testing page names the lab and the test numbers, and says plainly that each report is a supplier's sample with the batch “Unknown”, so it proves the lab report is real but not that any particular vial they sell matches it. Most product pages say “COA PENDING” rather than borrowing someone else's report. That's the most honest labelling I've seen.
Clean product pages. No dose tables and no disease claims, with lab research labelled as not proving results in people.
What dragged it down
The other blog: a dose guide. Older posts on the same site give injection doses, how often to take them and how long to cycle, for BPC-157, ipamorelin and others. One worked example reads like a personal plan for shoulder pain. Another says “In our Cape Town clinics”. I'm not repeating any of their doses here.
A paid dosing programme. The “12-Week Fat Loss Protocol” is a monthly subscription, with “Your protocol supply delivered monthly with clear dosing and timing instructions.” and a “German Certified” badge with no explanation. Their quiz says it “tells the doctor where to look”. All of this sits beside a product badge reading “RESEARCH ONLY · NO HUMAN-USE GUIDANCE”.
“Legal to sell and possess”. A May post says “peptides sold and labelled for laboratory research are legal to sell and possess”. SAHPRA's own page lists BPC-157, TB-500 and others as “illegally marketed peptides”. Their newer posts quote that SAHPRA page correctly, but the old claim is still live with no update note.
The shop contradicts the good posts. The cheat sheet says “Do not pair unregistered injectables into stacks”, and the shop has a stack builder offering a five-peptide bundle. The cheat sheet says “powder products are not equivalent” to the approved GLP-1 medicines, and the shop sells tirzepatide powder.
Facts that don't hold up.
| What they say | What I found |
|---|---|
| Research peptides are “legal to sell and possess” (S17) | SAHPRA lists BPC-157, TB-500 and others as illegally marketed peptides. |
| For tirzepatide and semaglutide, a personal or family history of pancreatitis is a contraindication | The tirzepatide label lists pancreatitis as a warning, not a contraindication. The listed contraindications are a history of a specific thyroid cancer and serious allergy. |
| An ARA-290 trial in type 2 diabetes, citing NCT02039687 | That trial number is a study in sarcoidosis. |
| 16 of the 41 PubMed links I checked | Open unrelated papers. Their MOTS-c study link, for example, opens an HPV vaccine trial. |
Lab reports: honest, but not theirs. The four published reports are all supplier samples with no batch, two of them at a different strength from what's sold, and none for a batch they sell. Yet a product landing page still says “every batch is third-party HPLC tested at Janoshik Analytical”.
The reviews. The same three “Verified” five-star reviews, including “COA included with every order. Highly recommend.”, appear word for word on at least four different product pages, several of which say “COA PENDING”. Their own reviews page says “No moderated reviews published yet”. A review on the retatrutide page describes personal use.
The basics. They publish a company name, registration number and director, which few SA shops do. But the footer gives a Milnerton address and the legal page a different one in Cape Town (S21), the home page says prices include VAT with no VAT number shown, and same-day dispatch is promised while every product is on a 2 to 3 week pre-order.
What would get them a better grade
- Bring the older posts up to the standard of the new ones: take out the dose plans and cycles, and the “clinics” lines.
- Correct or remove “legal to sell and possess”, with an update note.
- Drop the dosing instructions from the fat-loss programme, or stop calling the products research use only.
- Fix the 16 wrong PubMed links and the mislabelled trial.
- Publish a report for a batch they actually sell, and remove the “every batch tested” lines until they can.
- Remove the repeated reviews, and settle on one address.
Do that and this is an 8 or 9. Most of the work is already done.
Their side
Peptide South Africa can reply any time through this form. If they do, I'll add it here word for word.
Spotted something I got wrong? Tell me. I fix facts fast and say what changed. I don't change a grade because someone complains, only when I've got a fact wrong or the supplier changes what they publish.
Evidence log
| Ref | What they said | Where | Seen |
|---|---|---|---|
| S01 | “BPC-157: animal healing research is not clinical proof” | /blog/peptide-cheat-sheet-south-africa · saved | 15 Oct 2026 |
| S02 | “Do not pair unregistered injectables into stacks” | /blog/peptide-cheat-sheet-south-africa · saved | 15 Oct 2026 |
| S03 | “powder products are not equivalent” | /blog/peptide-cheat-sheet-south-africa · saved | 15 Oct 2026 |
| S04 | “BPC-157, TB-500, MOTS-c, CJC-1295, tesamorelin and ipamorelin are prohibited at all times” | /blog/peptides-south-african-sport-wada-2026 · saved | 15 Oct 2026 |
| S05 | “do not establish SAHPRA registration, Section 21 authorisation” | /blog/south-africa-glp-1-recall-2026 · saved | 15 Oct 2026 |
| S06 | “Early, preclinical and observational evidence is labelled as such.” | /editorial-policy · saved | 15 Oct 2026 |
| S07 | “Its batch is reported as Unknown, so it verifies the published lab report—not a unique PSA vial or lot.” | /testing · saved | 15 Oct 2026 |
| S08 | “names Zztai Peptide Ltd. as the client” | /testing · saved | 15 Oct 2026 |
| S09 | “COA PENDING” | /product/bpc-tb500-blend · saved | 15 Oct 2026 |
| S10 | “COA included with every order. Highly recommend.” | /product/bpc-tb500-blend · saved | 15 Oct 2026 |
| S11 | “No moderated reviews published yet” | /reviews · saved | 15 Oct 2026 |
| S12 | Dose and frequency stated (not repeated here) | /blog/cjc-1295-ipamorelin-protocol · saved | 15 Oct 2026 |
| S13 | Dose and frequency stated (not repeated here) | /blog/bpc-157-tb-500-stack-guide · saved | 15 Oct 2026 |
| S14 | Dose and frequency stated (not repeated here) | /blog/how-to-track-peptide-cycles · saved | 15 Oct 2026 |
| S15 | “A peptide addressing both the local gut piece” | /blog/kpv-perimenopause-inflammation · saved | 15 Oct 2026 |
| S16 | “In our Cape Town clinics” | /blog/ara-290-south-africa · saved | 15 Oct 2026 |
| S17 | “peptides sold and labelled for laboratory research are legal to sell and possess” | /blog/bpc-157-south-africa · saved | 15 Oct 2026 |
| S18 | “Your protocol supply delivered monthly with clear dosing and timing instructions.” | /fat-loss-protocol · saved | 15 Oct 2026 |
| S19 | “German Certified” | /fat-loss-protocol · saved | 15 Oct 2026 |
| S20 | “COA documents are available on every product page.” | /faq · saved | 15 Oct 2026 |
| S21 | “Washington Street, Room 1 Block F” | /impressum · saved | 15 Oct 2026 |
| S22 | “RESEARCH ONLY · NO HUMAN-USE GUIDANCE” | /product/rt3-reta · saved | 15 Oct 2026 |
| S23 | Dose and frequency stated (not repeated here) | /blog/peptide-dosage-calculator · saved | 15 Oct 2026 |
| S24 | “every batch is third-party HPLC tested at Janoshik Analytical” | /buy-bpc-157-south-africa · saved | 15 Oct 2026 |
| S25 | “BPC-157 + Tesamorelin + GHK-Cu + SS-31 + MOTS-C” | /build-your-stack · saved | 15 Oct 2026 |
| S26 | “I started GGG-3 several weeks ago” | /product/rt3-reta · saved | 15 Oct 2026 |
| S27 | “This just tells the doctor where to look” | /quiz · saved | 15 Oct 2026 |
Update log
- 15 Oct 2026: First published.
Sources
- SAHPRA: Peptide products, public information (May 2026).
- Mounjaro (tirzepatide) US prescribing information: contraindications and warnings.
- ClinicalTrials.gov NCT02039687: ARA 290 in sarcoidosis.
- PubMed 31305011, the paper their MOTS-c citation links to (an HPV vaccine trial).
- USADA: BPC-157, a prohibited experimental peptide.
